单基因病胚胎植入前遗传学检测后妊娠的产科与围产结局
以色列Sheba医疗中心2006-2018年队列研究,比较单基因病PGT-M妊娠与自然妊娠及未行PGT的IVF妊娠的产科结局。PGT-M组单胎妊娠高血压疾病和小于胎龄儿风险显著高于两对照组,双胎妊娠高血压疾病风险亦升高。
要点
- PGT-M单胎妊娠高血压疾病发生率6.9%,显著高于自然妊娠2.3%和IVF 4.7%。
- PGT-M单胎妊娠小于胎龄儿发生率12.4%,显著高于自然妊娠3.9%和IVF 4.5%。
- PGT-M双胎妊娠高血压疾病风险亦较自然妊娠和IVF妊娠升高。
核心结论
- 与自然妊娠或未行PGT的IVF妊娠相比,单基因病PGT-M后妊娠与产科并发症风险增加相关。
研究设计与样本
- 以色列Sheba医疗中心2006至2018年回顾性队列研究。
- PGT-M组纳入345例单胎和76例双胎分娩。
- 自然妊娠组纳入5290例单胎和92例双胎分娩。
- IVF组纳入422例单胎和101例双胎分娩。
主要发现
- 单胎妊娠中PGT-M组高血压疾病发生率6.9%,自然妊娠组2.3%(OR 3.3,95%CI 1.9-4.8;aOR 14.8,95%CI 7.4-29.8),IVF组4.7%(OR 1.5,95%CI 0.8-2.7;aOR 5.9,95%CI 1.9-18.2)。
- 双胎妊娠中PGT-M组高血压疾病发生率4.3%,自然妊娠组4.3%(OR 4.1,95%CI 1.2-13.3;aOR 10.9,95%CI 2.3-50),IVF组4%(OR 4.5,95%CI 1.4-14.7;aOR 3.7,95%CI 1.1-12.8)。
临床怎么用
- 对PGT-M后妊娠应加强产科监测,重点关注妊娠期高血压疾病和胎儿生长受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To investigate whether the addition of embryo biopsy performed during preimplantation genetic testing for monogenic diseases is associated with a higher risk of obstetric and neonatal complications compared with in vitro fertilization (IVF) without preimplantation genetic testing or spontaneously conceived pregnancies. METHODS: This is a cohort study of all pregnancies conceived after preimplantation genetic testing for monogenic diseases (PGT-M group) from 2006 to 2018 at Sheba Medical Center, Israel. The control groups included patients who had conceived spontaneously (spontaneous conception group) or by IVF without preimplantation genetic testing (IVF group) and delivered at Sheba Medical Center. The obstetrics outcomes were compared among the groups. Multivariable regression modeling was performed, focusing on the relationship between preimplantation genetic testing and adverse outcomes. RESULTS: Final analysis included 345 singleton and 76 twin deliveries in the PGT-M group. The spontaneous conception group included 5,290 singleton and 92 twin deliveries. The IVF group included 422 singleton and 101 twin deliveries. Among singleton pregnancies, patients in the PGT-M group had a higher rate of hypertensive disorders (6.9%) compared with those in the spontaneous conception group (2.3%; odds ratio [OR] 3.3; 95% CI 1.9-4.8; adjusted odds ratio [aOR] 14.8; 95% CI 7.4-29.8) and the IVF group (4.7%; OR 1.5; 95% CI 0.8-2.7; aOR 5.9; 95% CI 1.9-18.2). Likewise, patients in the PGT-M group had a higher rate of small-for-gestational age neonates (12.4%) compared with those in the spontaneous conception group (3.9%; OR 3.4; 95% CI 2.4-4.9; aOR 2.3; 95% CI 1.5-3.4) and the IVF group (4.5%; OR 3; 95% CI 1.7-5.2; aOR 2.5; 95% CI 1.7-5.2). Among twin pregnancies, patients in the PGT-M group also had an increased rate of hypertensive disorders compared with those in the spontaneous conception group (4.3%; OR 4.1; 95% CI 1.2-13.3; aOR 10.9; 95% CI 2.3-50) and the IVF group (4%; OR 4.5; 95% CI 1.4-14.7; aOR 3.7; 95% CI 1.1-12.8). CONCLUSION: Pregnancies conceived after preimplantation genetic testing for monogenic disorders were associated with an increased risk of obstetric complications compared with pregnancies conceived spontaneously or by IVF without preimplantation genetic testing.
引用
- Feldman B, Orvieto R, Weisel M, et al. Obstetric and Perinatal Outcomes in Pregnancies Conceived After Preimplantation Genetic Testing for Monogenetic Diseases. Obstet Gynecol. 2020. PMID: 32925631. doi:10.1097/AOG.0000000000004062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。